Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Park GB et al. – The results indicate that B7–H4–mediated signalling on EBV–positive B–cell lymphoma cells modulates the cell cycle through down–regulation of the AKT pathway. Consequently, B7–H4 may be a new potential target for use in EBV–positive lymphoma therapy.

Related Articles

Lymphoma in patients treated with anti-TNF. Results of the 3-year prospective French RATIO registry.
Annals of Rheumatic Diseases, 10/22/09    Relevance Score: 96%

Do male lymphoma survivors have impaired sexual function?
Journal of Clinical Oncology, 10/29/09    Relevance Score: 94%

Subcutaneous ‘lipoma-like’ B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT
Annals of Oncology, 10/29/09    Relevance Score: 94%

Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach
Hematological Oncology, 10/27/09    Relevance Score: 94%

Phase I/II Study of Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: Japan Clinical Oncology Group Study JCOG0211
Journal of Clinical Oncology, 10/12/09    Relevance Score: 93%

Today in Allergy/Immunology...keeping you current

Allergic skin diseases
Journal of Allergy and Clinical Immunology, 12/01/09

A Patient with Bronchial Asthma in Whom Eosinophilic Bronchitis and Bronchiolitis Developed during Treatment
Allergology International, 12/01/09

Occupational Allergy in Strawberry Greenhouse Workers
International Archives of Allergy and Immunology, 12/01/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address